As the industry prepares for DCAT Week, one of the most important gatherings for pharma outsourcing and partnerships, 24/7 Biopharma convened a group of industry experts to share their perspectives on the market’s direction.
‍

In this roundtable, Erin LaMarca, Business Development Manager at Tjoapack, outlines how the outsourcing landscape is moving into a more measured and strategic phase. Rather than broad expansion, companies are taking a more selective approach—prioritising late-stage, high-value programs while applying greater scrutiny to early-stage investments.

‍